BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12371853)

  • 1. 3-pyrrolines are mechanism-based inactivators of the quinone-dependent amine oxidases but only substrates of the flavin-dependent amine oxidases.
    Lee Y; Ling KQ; Lu X; Silverman RB; Shepard EM; Dooley DM; Sayre LM
    J Am Chem Soc; 2002 Oct; 124(41):12135-43. PubMed ID: 12371853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly potent 3-pyrroline mechanism-based inhibitors of bovine plasma amine oxidase and mass spectrometric confirmation of cofactor derivatization.
    Zhang Y; Ran C; Zhou G; Sayre LM
    Bioorg Med Chem; 2007 Feb; 15(4):1868-77. PubMed ID: 17150363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic turnover of substrate benzylamines by the quinone-dependent plasma amine oxidase leads to H2O2-dependent inactivation: evidence for generation of a cofactor-derived benzoxazole.
    Lee Y; Shepard E; Smith J; Dooley DM; Sayre LM
    Biochemistry; 2001 Jan; 40(3):822-9. PubMed ID: 11170400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of bovine plasma amine oxidase by homopropargylamine, a new inactivator motif.
    Qiao C; Jeon HB; Sayre LM
    J Am Chem Soc; 2004 Jun; 126(25):8038-45. PubMed ID: 15212554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based cofactor derivatization of a copper amine oxidase by a branched primary amine recruits the oxidase activity of the enzyme to turn inactivator into substrate.
    Qiao C; Ling KQ; Shepard EM; Dooley DM; Sayre LM
    J Am Chem Soc; 2006 May; 128(18):6206-19. PubMed ID: 16669691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of bovine plasma amine oxidase by haloallylamines.
    Kim J; Zhang Y; Ran C; Sayre LM
    Bioorg Med Chem; 2006 Mar; 14(5):1444-53. PubMed ID: 16266805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of six copper amine oxidases by a family of 4-(aryloxy)-2-butynamines: evidence for a new mode of inactivation.
    O'Connell KM; Langley DB; Shepard EM; Duff AP; Jeon HB; Sun G; Freeman HC; Guss JM; Sayre LM; Dooley DM
    Biochemistry; 2004 Aug; 43(34):10965-78. PubMed ID: 15323556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based inactivators of plant copper/quinone containing amine oxidases.
    Longu S; Mura A; Padiglia A; Medda R; Floris G
    Phytochemistry; 2005 Aug; 66(15):1751-8. PubMed ID: 16054177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards the development of selective amine oxidase inhibitors. Mechanism-based inhibition of six copper containing amine oxidases.
    Shepard EM; Smith J; Elmore BO; Kuchar JA; Sayre LM; Dooley DM
    Eur J Biochem; 2002 Aug; 269(15):3645-58. PubMed ID: 12153561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of 1,3,5-triphenyl-4,5-dihydro-(1H)-pyrazole derivatives on activity of amine oxidases.
    Manna F; Chimenti F; Bolasco A; Bizzarri B; Befani O; Pietrangeli P; Mondovi B; Turini P
    J Enzyme Inhib; 1998 Jun; 13(3):207-16. PubMed ID: 9629538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of bovine plasma amine oxidase by 4-aryloxy-2-butynamines and related analogs.
    Jeon HB; Sun G; Sayre LM
    Biochim Biophys Acta; 2003 Apr; 1647(1-2):343-54. PubMed ID: 12686156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and enzyme activity studies demonstrate that aryl substituted 2,3-butadienamine analogs inactivate Arthrobacter globiformis amine oxidase (AGAO) by chemical derivatization of the 2,4,5-trihydroxyphenylalanine quinone (TPQ) cofactor.
    Ernberg K; Zhong B; Ko K; Miller L; Nguyen YH; Sayre LM; Guss JM; Lee I
    Biochim Biophys Acta; 2011 May; 1814(5):638-46. PubMed ID: 21215824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible inactivation of bovine plasma amine oxidase by cysteamine and related analogs.
    Jeon HB; Jang Y
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):442-6. PubMed ID: 21094148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly potent propargylamine and allylamine inhibitors of bovine plasma amine oxidase.
    Jeon HB; Sayre LM
    Biochem Biophys Res Commun; 2003 May; 304(4):788-94. PubMed ID: 12727226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative sensitivities of purified preparations of lysyl oxidase and other amine oxidases to active site-directed enzyme inhibitors.
    Tang SS; Chichester CO; Kagan HM
    Connect Tissue Res; 1989; 19(1):93-103. PubMed ID: 2571459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of six copper-containing amine oxidases by the antidepressant drug tranylcypromine.
    Shepard EM; Heggem H; Juda GA; Dooley DM
    Biochim Biophys Acta; 2003 Apr; 1647(1-2):252-9. PubMed ID: 12686142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of copper-containing amine oxidases by turnover products.
    Pietrangeli P; Nocera S; Federico R; Mondovì B; Morpurgo L
    Eur J Biochem; 2004 Jan; 271(1):146-52. PubMed ID: 14686927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y; Stepita-Klauco M
    Experientia; 1980 May; 36(5):535-7. PubMed ID: 6769699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of bovine plasma amine oxidase by 1,4-diamino-2-butenes and -2-butynes.
    Jeon HB; Lee Y; Qiao C; Huang H; Sayre LM
    Bioorg Med Chem; 2003 Oct; 11(21):4631-41. PubMed ID: 14527560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amine oxidases from Aspergillus niger: identification of a novel flavin-dependent enzyme.
    Schilling B; Lerch K
    Biochim Biophys Acta; 1995 Apr; 1243(3):529-37. PubMed ID: 7727530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.